Officers
President: Mike Fisher, PhD, FRSC
​Chief Commercial Officer, Oncimmune – An Alden Scientific Company
Mike leads the organization's activities in the life sciences sector.
Mike has a PhD in medicinal chemistry and 28 years’ experience of life sciences business development, commercialisation, project management and government relations. He has worked in both the public and private sectors, focusing on biotech business development for the past 16 years.
Mike joined Oncimmune in 2017 and drove the adoption strategy for EarlyCDT Lung in the UK/Europe and Oncimmune’s move into precision medicine services. Following the sale of the early cancer detection business in 2023, Mike rebuilt Oncimmune’s Commercial Team and relocated the BD office to Boston MA, USA where he is now based. Mike joined Oncimmune from Abcodia, where he was Director of Strategic Alliances, focusing on biomarker validation for early detection of cancer and other diseases.
Before this he was Business Development Director for Bio Nano Consulting, a spin-out from University College London and Imperial College.
Between 2005 and 2008, Mike was the UK government’s Life Sciences Industry Advisor for North America, based in Cambridge MA, where he liaised between US corporates and the UK Department of Health, NICE and MHRA.
Prior to moving to the US Mike worked in life science economic development in the public sector and provided internationalisation consultancy to life science companies. Mike performed his post-doctoral research at DSTL Porton Down, developing detection systems for toxins and pathogens, where he became the Project Manager for their Blue Sky research programmes in biological detection.
In addition, Mike is the founder of the Boston Biotech Brits, a member of the Advisory Board of BioPartner UK and the European Producer for TechNation and BiotechNation on National Public Radio.
​
Vice President: Jane Ollerhead
Director, Business Banking, Capital One
Jane has 20+ years of international business experience. At Capital One, she works with business owners and emerging mid-market clients across New England, providing banking solutions that make managing finances easy—so they can stay focused on growth and success. She is the former Treasurer of BABCNE and Women in World Trade, New England.
Clerk: Kevin MacDonald, PhD, Esq. Shareholder
IP Strategy Counselor and Patent Attorney, Biotechnology Group
Wolf Greenfield
Kevin MacDonald is a shareholder at Wolf Greenfield, where he assists clients with IP strategy, portfolio management, patent prosecution, and counseling across a wide range of life sciences technologies. His work spans areas such as cell and gene therapy, RNA interference, bioinformatics, mRNA therapeutics, and biologics manufacturing.
Kevin represents clients at every stage of growth, including venture-backed startups, large biopharma companies, public and private universities, and research institutions. He also advises clients in buy- and sell-side IP due diligence and handles the drafting and negotiation of IP-centric agreements, including licensing agreements, sponsored research agreements, and technology collaboration agreements.
Before entering practice, Kevin earned his PhD from the Institute of Parasitology at McGill University and his MSc from the Liverpool School of Tropical Medicine.
Executive Director: Urszula Wojciechowska, MBE
Urszula is an accomplished executive with over 25 years of professional experience in management and leadership, event and strategic planning, marketing, business development, and project management on both national and international levels.
As a proactive leader in the transatlantic business community, Urszula is dedicated to facilitating trade between the United States and the United Kingdom, enhancing relationships for U.S. companies interested in exporting, and supporting collaborations among companies in New England and the United Kingdom.
In her capacity as the Executive Director of the British American Business Council of New England, Urszula plays a pivotal role in advancing transatlantic commerce and fostering business connections. Furthermore, she is the Founder of the Global Business Alliance of New England, which promotes international business partnerships, and she serves as Co-Founder of Women in World Trade, New England, an organization that champions women in the global marketplace.
Urszula was appointed a Member of the Most Excellent Order of the British Empire (MBE) in the 2016 Queen Elizabeth 11 New Year Honors List, “for services to British, American and international communities in North America and the United Kingdom”.
She has a diverse background in education, public relations, marketing, and international affairs.
